CTOs on the Move


 
Healthcare organizations and technology vendors connect to Redox once, then authorize what data they send to and receive from partners through a centralized hub. Redox`s cloud-based platform is vendor and standards agnostic and enables the secure and efficient exchange of healthcare data. This approach eradicates the need for point-to-point integrations and accelerates the discovery, adoption, and distribution of patient and provider-facing technology solutions. With hundreds of healthcare organizations and technology vendors exchanging data today, Redox represents the largest interoperable network in healthcare.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Tim Kessler
Field CTO Profile

Funding

Redox raised $33M on 04/17/2019
Redox raised $45M on 02/24/2021

Similar Companies

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

Senior Network, The

Senior Network, The is a Stamford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nikon Instruments

Nikon Instruments is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Paragon Medical

Paragon Medical is a turnkey supplier of world-class solutions for cases and trays, surgical instrumentation (reusable and single-use), implantable components, and design & development services to the medical device marketplace.

IntelliType Corporation

IntelliType Corporation is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.